Back to trial detailsIntake questionnaire
EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Applying to Michael E. DeBakey VA Medical Center, Houston, TX · Houston, Texas
Answer a few short questions to share with the research team.
0 of 3 answered